High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer
High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer
Active, not recruiting · NCT01646034 · Registry updated 2022-10-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2022-10-12 | NCT01646034 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The Netherlands Cancer Institute | 113 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| NKI-AvL | Amsterdam | Netherlands | 4 |